Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
Thymalin structure

Thymalin

Immune
Phase 2 Research
55%
Low Risk
1/5

Dosing Protocol

Typical Dose 10 mg
Range 5 - 20 mg
Loading Phase 10 mg × 10 days
Cycle 2w on / 24w off

Pharmacokinetics

Half-Life 5 min
Onset 30 min
Peak 1.0 hrs
Duration 7.0 days
Bioavailability 85%
Primary Route Intramuscular

Administration

Routes Intramuscular, Subcutaneous
Injection Sites Deltoid, Thigh, Glute
Needle Gauge 25-27G
Syringe Type Standard
Timing Morning

Reconstitution

Diluent Sterile Water
Volume 2 mL
Stability 7 days refrigerated
Vial Sizes 10 mg

Special Instructions

Zinc-dependent activity - ensure adequate zinc status. Used in 5-10 day cycles. Immune effects persist for weeks after course. Russian medical registration.